AtaiBeckley Shares Soar on Reports of Eli Lilly Acquisition Talks
AtaiBeckley Inc. stock jumped 52.2% in pre-market trading after media reports indicated Eli Lilly is in advanced discussions to buy the psychedelic drug developer at a premium. The surge follows growing investor interest in psychedelic therapies, recent regulatory guidance affecting trial protocols and commentary from analysts and venture capital f…